US Stock MarketDetailed Quotes

Atossa Therapeutics (ATOS)

Watchlist
  • 4.490
  • +0.020+0.45%
Trading Jun 8 12:27 ET
38.67MMarket Cap-1.03P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Atossa Therapeutics (ATOS) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
33.13%9.87M
34.47%37.14M
59.92%11.44M
44.89%9.25M
27.23%9.04M
6.22%7.41M
-11.97%27.62M
-20.71%7.15M
-14.50%6.39M
-8.83%7.11M
Selling and administrative expenses
56.31%5.09M
18.16%15.96M
40.88%5.28M
30.54%3.88M
-0.39%3.54M
0.77%3.26M
-3.84%13.5M
11.38%3.75M
-0.93%2.97M
-13.11%3.55M
-General and administrative expense
56.31%5.09M
18.16%15.96M
40.88%5.28M
30.54%3.88M
-0.39%3.54M
0.77%3.26M
-3.84%13.5M
11.38%3.75M
-0.93%2.97M
-13.11%3.55M
Research and development costs
14.96%4.78M
50.07%21.19M
80.90%6.16M
57.39%5.37M
54.86%5.5M
10.91%4.16M
-18.56%14.12M
-39.81%3.4M
-23.62%3.41M
-4.10%3.55M
Operating profit
-33.13%-9.87M
-34.47%-37.14M
-59.92%-11.44M
-44.89%-9.25M
-27.23%-9.04M
-6.22%-7.41M
11.97%-27.62M
20.71%-7.15M
14.50%-6.39M
8.83%-7.11M
Net non-operating interest income expense
-57.08%309K
-41.31%2.38M
-47.19%442K
-43.06%570K
-39.89%645K
-36.73%720K
-6.75%4.05M
-32.28%837K
-21.43%1M
9.16%1.07M
Non-operating interest income
-57.08%309K
-41.31%2.38M
-47.19%442K
-43.06%570K
-39.89%645K
-36.73%720K
-6.75%4.05M
-32.28%837K
-21.43%1M
9.16%1.07M
Other net income (expense)
-16.67%-28K
99.69%-6K
272.73%57K
99.40%-11K
-64.71%-28K
33.33%-24K
36.83%-1.93M
-213.79%-33K
-5,174.29%-1.85M
99.44%-17K
Special income (charges)
----
--0
--0
--0
----
----
42.81%-1.71M
--0
---1.71M
--0
-Write off
----
--0
--0
--0
----
----
-42.81%1.71M
--0
--1.71M
--0
Other non- operating income (expenses)
-16.67%-28K
97.31%-6K
272.73%57K
91.91%-11K
-64.71%-28K
33.33%-24K
-218.57%-223K
-213.79%-33K
-288.57%-136K
43.33%-17K
Income before tax
-42.74%-9.59M
-36.33%-34.77M
-72.32%-10.94M
-20.22%-8.69M
-39.25%-8.42M
-14.29%-6.72M
15.25%-25.5M
18.15%-6.35M
-16.07%-7.23M
38.46%-6.05M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
-42.74%-9.59M
-36.33%-34.77M
-72.32%-10.94M
-20.22%-8.69M
-39.25%-8.42M
-14.29%-6.72M
15.25%-25.5M
18.15%-6.35M
-16.07%-7.23M
38.46%-6.05M
Net income continuous Operations
-42.74%-9.59M
-36.33%-34.77M
-72.32%-10.94M
-20.22%-8.69M
-39.25%-8.42M
-14.29%-6.72M
15.25%-25.5M
18.15%-6.35M
-16.07%-7.23M
38.46%-6.05M
Minority interest income
Net income attributable to the parent company
-42.74%-9.59M
-36.33%-34.77M
-72.32%-10.94M
-20.22%-8.69M
-39.25%-8.42M
-14.29%-6.72M
15.25%-25.5M
18.15%-6.35M
-16.07%-7.23M
38.46%-6.05M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-42.74%-9.59M
-36.33%-34.77M
-72.32%-10.94M
-20.22%-8.69M
-39.25%-8.42M
-14.29%-6.72M
15.25%-25.5M
18.15%-6.35M
-16.07%-7.23M
38.46%-6.05M
Basic earnings per share
-42.31%-1.11
-32.89%-4.04
-69.62%-1.34
-16.67%-1.05
-40.00%-1.05
-4.00%-0.78
15.56%-3.04
12.22%-0.79
-20.00%-0.9
37.50%-0.75
Diluted earnings per share
-42.31%-1.11
-32.89%-4.04
-69.62%-1.34
-16.67%-1.05
-40.00%-1.05
-4.00%-0.78
15.56%-3.04
12.22%-0.79
-20.00%-0.9
37.50%-0.75
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 33.13%9.87M34.47%37.14M59.92%11.44M44.89%9.25M27.23%9.04M6.22%7.41M-11.97%27.62M-20.71%7.15M-14.50%6.39M-8.83%7.11M
Selling and administrative expenses 56.31%5.09M18.16%15.96M40.88%5.28M30.54%3.88M-0.39%3.54M0.77%3.26M-3.84%13.5M11.38%3.75M-0.93%2.97M-13.11%3.55M
-General and administrative expense 56.31%5.09M18.16%15.96M40.88%5.28M30.54%3.88M-0.39%3.54M0.77%3.26M-3.84%13.5M11.38%3.75M-0.93%2.97M-13.11%3.55M
Research and development costs 14.96%4.78M50.07%21.19M80.90%6.16M57.39%5.37M54.86%5.5M10.91%4.16M-18.56%14.12M-39.81%3.4M-23.62%3.41M-4.10%3.55M
Operating profit -33.13%-9.87M-34.47%-37.14M-59.92%-11.44M-44.89%-9.25M-27.23%-9.04M-6.22%-7.41M11.97%-27.62M20.71%-7.15M14.50%-6.39M8.83%-7.11M
Net non-operating interest income expense -57.08%309K-41.31%2.38M-47.19%442K-43.06%570K-39.89%645K-36.73%720K-6.75%4.05M-32.28%837K-21.43%1M9.16%1.07M
Non-operating interest income -57.08%309K-41.31%2.38M-47.19%442K-43.06%570K-39.89%645K-36.73%720K-6.75%4.05M-32.28%837K-21.43%1M9.16%1.07M
Other net income (expense) -16.67%-28K99.69%-6K272.73%57K99.40%-11K-64.71%-28K33.33%-24K36.83%-1.93M-213.79%-33K-5,174.29%-1.85M99.44%-17K
Special income (charges) ------0--0--0--------42.81%-1.71M--0---1.71M--0
-Write off ------0--0--0---------42.81%1.71M--0--1.71M--0
Other non- operating income (expenses) -16.67%-28K97.31%-6K272.73%57K91.91%-11K-64.71%-28K33.33%-24K-218.57%-223K-213.79%-33K-288.57%-136K43.33%-17K
Income before tax -42.74%-9.59M-36.33%-34.77M-72.32%-10.94M-20.22%-8.69M-39.25%-8.42M-14.29%-6.72M15.25%-25.5M18.15%-6.35M-16.07%-7.23M38.46%-6.05M
Income tax 0000000000
Net income -42.74%-9.59M-36.33%-34.77M-72.32%-10.94M-20.22%-8.69M-39.25%-8.42M-14.29%-6.72M15.25%-25.5M18.15%-6.35M-16.07%-7.23M38.46%-6.05M
Net income continuous Operations -42.74%-9.59M-36.33%-34.77M-72.32%-10.94M-20.22%-8.69M-39.25%-8.42M-14.29%-6.72M15.25%-25.5M18.15%-6.35M-16.07%-7.23M38.46%-6.05M
Minority interest income
Net income attributable to the parent company -42.74%-9.59M-36.33%-34.77M-72.32%-10.94M-20.22%-8.69M-39.25%-8.42M-14.29%-6.72M15.25%-25.5M18.15%-6.35M-16.07%-7.23M38.46%-6.05M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -42.74%-9.59M-36.33%-34.77M-72.32%-10.94M-20.22%-8.69M-39.25%-8.42M-14.29%-6.72M15.25%-25.5M18.15%-6.35M-16.07%-7.23M38.46%-6.05M
Basic earnings per share -42.31%-1.11-32.89%-4.04-69.62%-1.34-16.67%-1.05-40.00%-1.05-4.00%-0.7815.56%-3.0412.22%-0.79-20.00%-0.937.50%-0.75
Diluted earnings per share -42.31%-1.11-32.89%-4.04-69.62%-1.34-16.67%-1.05-40.00%-1.05-4.00%-0.7815.56%-3.0412.22%-0.79-20.00%-0.937.50%-0.75
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +8.96%
Sample Name
Sample Code
 +5.35%
Sample Name
Sample Code
 +2.95%
4
VanEck Oil Services ETF
OIH
+2.63%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+2.61%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +23.44%
Sample Name
Sample Code
 +0.76%
Sample Name
Sample Code
 +0.56%
4
H World Group
HTHT
-0.48%
5
Yum China
YUMC
-0.56%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Iran's Fars News Agency, the Iranian armed forces announced the conclusion of their military operations against Israel but warn Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -